Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis

Mark A. Rubin, Bernard Kleter, Ming Zhou, Gustavo Ayala, Antonio L. Cubilla, Wim G.V. Quint, Edyta C. Pirog

Research output: Contribution to journalArticle

315 Citations (Scopus)

Abstract

To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42% cases of penile carcinoma, 90% cases of dysplasia, and 100% cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3% of cases, respectively, HPV DNA was detected in 80% of basaloid and 100% of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42%) is lower than that in cervical carcinoma (∼100%) and similar to vulvar carcinoma (∼50%). In addition, specific histological subtypes of penile cancer - basaloid and warty - are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.

Original languageEnglish (US)
Article number62506
Pages (from-to)1211-1218
Number of pages8
JournalAmerican Journal of Pathology
Volume159
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Carcinogenesis
Carcinoma
DNA
Paraguay
Verrucous Carcinoma
Penile Neoplasms
Neoplasms
Paraffin
Formaldehyde
Squamous Cell Carcinoma
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Detection and typing of human papillomavirus DNA in penile carcinoma : Evidence for multiple independent pathways of penile carcinogenesis. / Rubin, Mark A.; Kleter, Bernard; Zhou, Ming; Ayala, Gustavo; Cubilla, Antonio L.; Quint, Wim G.V.; Pirog, Edyta C.

In: American Journal of Pathology, Vol. 159, No. 4, 62506, 01.01.2001, p. 1211-1218.

Research output: Contribution to journalArticle

Rubin, Mark A. ; Kleter, Bernard ; Zhou, Ming ; Ayala, Gustavo ; Cubilla, Antonio L. ; Quint, Wim G.V. ; Pirog, Edyta C. / Detection and typing of human papillomavirus DNA in penile carcinoma : Evidence for multiple independent pathways of penile carcinogenesis. In: American Journal of Pathology. 2001 ; Vol. 159, No. 4. pp. 1211-1218.
@article{6d2f2253eb7b43a69ac15c00a9181b8e,
title = "Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis",
abstract = "To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42{\%} cases of penile carcinoma, 90{\%} cases of dysplasia, and 100{\%} cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3{\%} of cases, respectively, HPV DNA was detected in 80{\%} of basaloid and 100{\%} of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42{\%}) is lower than that in cervical carcinoma (∼100{\%}) and similar to vulvar carcinoma (∼50{\%}). In addition, specific histological subtypes of penile cancer - basaloid and warty - are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.",
author = "Rubin, {Mark A.} and Bernard Kleter and Ming Zhou and Gustavo Ayala and Cubilla, {Antonio L.} and Quint, {Wim G.V.} and Pirog, {Edyta C.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0002-9440(10)62506-0",
language = "English (US)",
volume = "159",
pages = "1211--1218",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Detection and typing of human papillomavirus DNA in penile carcinoma

T2 - Evidence for multiple independent pathways of penile carcinogenesis

AU - Rubin, Mark A.

AU - Kleter, Bernard

AU - Zhou, Ming

AU - Ayala, Gustavo

AU - Cubilla, Antonio L.

AU - Quint, Wim G.V.

AU - Pirog, Edyta C.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42% cases of penile carcinoma, 90% cases of dysplasia, and 100% cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3% of cases, respectively, HPV DNA was detected in 80% of basaloid and 100% of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42%) is lower than that in cervical carcinoma (∼100%) and similar to vulvar carcinoma (∼50%). In addition, specific histological subtypes of penile cancer - basaloid and warty - are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.

AB - To clarify the role of human papillomavirus (HPV) in penile cancer we evaluated the prevalence of HPV DNA in different histological subtypes of penile carcinoma, dysplasia, and condyloma using a novel, sensitive SPF10 HPV polymerase chain reaction assay and a novel genotyping line probe assay, allowing simultaneous identification of 25 different HPV types. Formalin-fixed, paraffin-embedded tissue samples were collected from the United States and Paraguay. HPV DNA was detected in 42% cases of penile carcinoma, 90% cases of dysplasia, and 100% cases of condyloma. There were significant differences in HPV prevalence in different histological cancer subtypes. Although keratinizing squamous cell carcinoma and verrucous carcinoma were positive for HPV DNA in only 34.9 and 33.3% of cases, respectively, HPV DNA was detected in 80% of basaloid and 100% of warty tumor subtypes. There was no significant difference in HPV prevalence between cases from Paraguay and the United States. In conclusion, the overall prevalence of HPV DNA in penile carcinoma (42%) is lower than that in cervical carcinoma (∼100%) and similar to vulvar carcinoma (∼50%). In addition, specific histological subtypes of penile cancer - basaloid and warty - are consistently associated with HPV, however, only a subset of keratinizing and verrucous penile carcinomas is positive for HPV DNA, and thus these two tumor groups seem to develop along different pathogenetic pathways.

UR - http://www.scopus.com/inward/record.url?scp=0034795914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034795914&partnerID=8YFLogxK

U2 - 10.1016/S0002-9440(10)62506-0

DO - 10.1016/S0002-9440(10)62506-0

M3 - Article

C2 - 11583947

AN - SCOPUS:0034795914

VL - 159

SP - 1211

EP - 1218

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

M1 - 62506

ER -